To assess whether MYC functioned as a cell-intrinsic mediator of mTORi resistance, we leveraged pharmacogenomic datasets derived from a compendium of human cancer cell lines (Gao et al., 2013; Barretina et al., 2012; Yang et al., 2013). This evidence concerns the gene MYC and cancer.